As of 2025-12-31, the Fair Value of Viking Therapeutics Inc (VKTX) is -10.50 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 35.32 USD, the upside of Viking Therapeutics Inc is -129.73%.
With the market price of 35.32 USD and our fair value calculation, Viking Therapeutics Inc (VKTX) is not a good investment. Investing in VKTX stocks now will result in a potential loss of 129.73%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -39.50 | -54.99 | -68.87 | -85.89 | -109.96 | -71.84 |
| YoY growth | -53.22% | -39.22% | -25.24% | -24.72% | -28.02% | -34.08% |
| Market Cap (mil) | 3,992.57 |
| P/E | |
| Forward P/E |
| EPS | -2.10 |
| Avg earnings growth rate | -34.08% |
| TTM earnings | -237.39 |